(MedPage Today) — Despite the curative potential of CAR T-cell therapy in multiple myeloma and other hematologic cancers, only a fraction of eligible patients currently receive it. At the recent American Society of Clinical Oncology meeting, Jason…
Source link : https://www.medpagetoday.com/meetingcoverage/ascofuturefocusmm/116219
Author :
Publish date : 2025-06-24 16:09:00
Copyright for syndicated content belongs to the linked Source.
